Donoghue Forlines’s Omnicell OMCL Stock Holding History

Donoghue Forlines’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,996	Closed	-$389K	–	230
2021 Q1	$389K	Sell	2,996 -9,995	-77%	-$1.28M	0.08%	194
2020 Q4	$1.56M	Buy	+12,991	New	+$1.27M	0.3%	69

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Donoghue Forlines's OMCL Position: Q2 2021 in Review

Donoghue Forlines sold out of Omnicell (OMCL) in Q2 2021, closing a stake of 2,996 shares — an estimated $389K sold.

Donoghue Forlines first reported a position in OMCL in Q4 2020 and held it in 2 quarters. The position peaked at $1.56M in Q4 2020. 377 funds tracked by Wall St. Rank hold OMCL as of Q2 2021.

Donoghue Forlines reported no remaining Omnicell position as of Q2 2021 after selling out during the quarter.
Donoghue Forlines sold 2,996 Omnicell shares in Q2 2021, an estimated $389K.
Donoghue Forlines first reported a position in Omnicell in Q4 2020 and held it in 2 quarters.
Donoghue Forlines's Omnicell position peaked at $1.56M in Q4 2020.
377 funds tracked by Wall St. Rank held Omnicell as of Q2 2021.

Based on Donoghue Forlines's 13F filing for Q2 2021, filed 16 Aug 2021.